A Pre-Amplification-Free Modular Dual-CRISPR System for Enhanced Pathogen Detection Sensitivity
- 25 November 2025
- journal article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (48) , 26640-26648
Abstract
CRISPR/Cas12a is extensively utilized for pathogen detection owing to its high specificity and efficiency. However, traditional single-CRISPR/Cas12a encounters challenges due to its limited sensitivity, requiring pre-amplification of nucleic acids. This increases the complexity of the procedure and the potential for cross-contamination and false positives. Herein, a modular dual-CRISPR approach was developed coupled with hybridization chain reaction (HCR) for the universal and sensitive detection of pathogen nucleic acids without the need for pre-amplification. The system comprises two core modules: the first CRISPR/Cas12a recognition module specifically identifies pathogen targets and releases the activating agent, while the second CRISPR/Cas12a signal module is activated by this agent to initiate the HCR reaction for generating a strong fluorescent signal through DNA nanostructure self-assembly. Through rational design, we demonstrate the ability of this dual-CRISPR system to achieve attomolar (aM) level sensitivity for pathogen nucleic acid detection without pre-amplification, showing over six-order-of-magnitude higher sensitivity than a traditional single-CRISPR/Cas12a system. Additionally, the flexibility and versatility of the modular dual-CRISPR system have been confirmed for diverse pathogen targets, such as African swine fever virus (ASFV), severe fever with thrombocytopenia syndrome virus (SFTSV), and human papillomavirus type 16 (HPV-16) DNA. The system's practicality was demonstrated by examining ASFV quality control samples in complex environments. The exploration of the pre-amplification-free dual-CRISPR system offers a new perspective on enhancing pathogen nucleic acid detection systems.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20212012)
- Nanjing University of Posts and Telecommunications (GZR2022010026)
- National Natural Science Foundation of China (62071251, 62227803, 62235008, 62288102)
- Belt and Road Innovation Cooperation Project of Jiangsu (BZ2022011)
- State Key Laboratory of Transducer Technology (SKT2306)
This publication has 37 references indexed in Scilit:
- Development of a universal one-pot CRISPR assay based on multifunctional tagged primer eliminating unstable crRNA input and PAM dependency for point-of-care detection of bacterial infectionsBiosensors and Bioelectronics, 2025
- Music-Box: Controlling microfluidic flow with customized melodies for point-of-care testingBiosensors and Bioelectronics, 2025
- "Turn-on" aptamer-immune lateral flow assays for the detection of small molecule targets based on CHA-assisted and CRISPR/Cas12a mediated signal transduction and amplificationBiosensors and Bioelectronics, 2025
- Light‐Triggered CRISPR/Cas12a for Genomic Editing and Tumor RegressionAngewandte Chemie International Edition, 2025
- Enhanced the Trans‐Cleavage Activity of CRISPR‐Cas12a Using Metal‐Organic Frameworks as Stimulants for Efficient Electrochemical Sensing of Circulating Tumor DNAAdvanced Science, 2025
- High-efficiency detection of APE1 using a defective PAM-driven CRISPR-Cas12a self-catalytic biosensorBiosensors and Bioelectronics, 2025
- Cooperative effect of complementary antisense oligonucleotides and CRISPR effectors for universal DNA-based pathogen assay using nano-enabled colorimetryMaterials Today, 2024
- Framework‐Hotspot Enhanced Trans Cleavage of CRISPR‐Cas12a for Clinical Samples DetectionAngewandte Chemie International Edition, 2023
- CLIPON: A CRISPR‐Enabled Strategy that Turns Commercial Pregnancy Test Strips into General Point‐of‐Need Test DevicesAngewandte Chemie International Edition, 2022
- CRISPR/Cas13a‐Powered Electrochemical Microfluidic Biosensor for Nucleic Acid Amplification‐Free miRNA DiagnosticsAdvanced Materials, 2019